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Introduction 
The human body contains approximately 3.75*1013 cells (1). Every day the 
human body and each cell must withstand a range of potential dangers, it being 
viruses or bacteria wanting to occupy our abode, toxins or irradiation in our 
environment damaging our cells, or even the cells themselves make mistakes for 
example when replicating DNA. Nevertheless, most of the time we walk around 
quite healthy and unaware of the battles taking place within us, thanks to our body’s 
remarkable ability to maintain itself. Despite the great capacity to overcome 
dangers, nothing is error free. Bacteria or virus mutate, resisting our body’s immune 
system and the drugs we have available. We may be predisposed to diseases 
through our genetic make-up, or the cells might be exposed to damage so severe 
that it is not possible to repair it. A large part of the diseases we encounter today, we 
can combat with the help of knowledge and medicine derived from research. 
Understanding the smallest details of the cells can help us comprehend how a 
certain disease develops or how a drug will function. In this thesis molecular 
mechanisms are addressed that will benefit the understanding of how the cell is 
regulated. 
The eukaryotic cell cycle 
The eukaryotic cell goes through four coordinated processes in its cycle; cell 
growth, DNA replication, distribution of the duplicated chromosomes to daughter 
cells, and cell division. Mammalian cells in culture spend approximately 24 hours on 
the cell cycle (Figure 1). In the microscope we can clearly distinguish between 
Interphase and Mitosis. Interphase is comprised of the cell-cycle phases G1, S, and 
G2 and about 95% of the cell cycle is spent on these phases. The cells grow steadily 
during the course of Interphase and usually double in size during this time. Mitosis 
(M-phase) is the fourth cell-cycle phase and also the most dramatic for the cell. The 
cells distribute the daughter chromosomes and undergo cytokinesis (cell division) all 
within an hour. G1 (Gap1)-phase is usually the longest of the cell-cycle phases and is 
the interval (gap) between mitosis and initiation of replication. G1-phase is followed 
by S (synthesis)-phase, where the cells replicate their DNA. Before M-phase can 
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commence the cells go through an additional gap phase, G2-phase. Here the cells 
continue to grow and synthesize proteins required for mitosis.  
Chromosome replication is strictly confined to S-phase and the replicated 
chromosomes are distributed to daughter nuclei in an intricate series of events 
leading up to cell division. The correct order of events in the cell cycle is crucial for 
the cell to maintain its integrity and is controlled by several molecular mechanisms 
termed checkpoints. 
CDK-Cyclins 
Many proteins are involved in regulating the cell cycle, the most important 
being cyclin-dependent kinases (CDKs). CDKs vary in type and numbers between 
eukaryotic cells. In mammalian cells there are 4 different CDKs associated with the 
cell cycle whereas there is only one in yeast. However common for them all is their 
ability to phosphorylate various protein substrates that are involved in cell-cycle 
progression. CDKs are regulated by three major mechanisms: cyclin binding, 
phosphorylation, and CDK inhibitors (2,3). Checkpoints target CDK activity and can 
arrest the cell cycle by using either major mechanism to regulate CDK activity. As 
their name indicates, CDKs are dependent on cyclins for their activity. Cyclins do not 
have any enzymatic activity but activate CDKs by binding to them. Cyclins are 
synthesized and degraded throughout the cell cycle unlike CDKs that are 
constitutively expressed, so when a cyclin is degraded, the corresponding CDK 
becomes inactive (4). Cyclin D is synthesized in G1-phase and its concentration 
remains high until mitosis where it is degraded. Cyclin E is only expressed from late 
G1-phase until mid S-phase, controlling the G1-S transition. Cyclin A and B increase 
more slowly from G1 to a peak in S-phase and M-phase respectively, before rapid 
degradation (5). Together with the phosphorylation status of CDKs and the 
expression of different cyclins, the cyclin-CDK complexes guide the cell through the 
different cell cycle phases. If the cyclin is not degraded or if the phosphorylation 
status of CDKs is changed the cells are arrested in the cell cycle.  
5 
 
 
Figure 1: The cell cycle; illustrating the progression through the four phases regulated by different 
CDK/Cyclin complexes. Checkpoints are indicated in each cell cycle phase.  
Checkpoints 
Checkpoints serve as halting points throughout the cell cycle, stopping or pausing 
the cycle in the case of unfavorable conditions for the cell. Four cell-cycle 
checkpoints ensure proper cell division and genome stability (Figure 1). The G1-S 
checkpoint and G2-M checkpoint stop entry into S-phase and mitosis, respectively, 
after DNA damage. The intra-S checkpoint delays S-phase progression in response to 
DNA damage. These three checkpoints provide the cell with extra time to repair DNA 
damage before entering the next cell cycle phase (6). In M-phase we find the spindle 
assembly checkpoint that prevents separation of the duplicated chromosomes until 
each chromosome is properly attached to the spindle apparatus (7). Furthermore, 
the Nocut checkpoint prevents cytokinesis unless the chromosomes are properly 
separated (8). The importance of the checkpoints is underlined by findings that 
suggest that the checkpoint response upon DNA damage represent the first barrier 
against cancer in human cells (9,10). The work presented in this thesis revolves 
around G1-phase and the entry into S-phase and therefore the focus will be on the 
G1-S checkpoint. 
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The G1-S checkpoint 
The main regulators for checkpoints are ATR and ATM in cooperation with 
the checkpoint kinases Chk1 and Chk2 (11). This is also true for the G1-S checkpoint. 
This checkpoint can be activated via two pathways, one that induces a rapid and 
transient response and one that induces a sustained and slower response. The initial 
and rapid G1 arrest is triggered by a swift cascade of phosphorylation events, 
involving ATM-dependent activation of Chk2 after ionizing radiation (IR) and ATR-
dependent activation of Chk1 after ultraviolet (UV) light (200-280 nm) (12). These 
kinases in turn phosphorylate the Cdc25A phosphatase, thereby priming it for 
ubiquitination and rapid degradation by the proteasome. The absence of Cdc25A 
phosphatase activity forces CDK2 to remain in its inactive form, resulting in the 
failure to load Cdc45 onto chromatin, and a rapid blockade of initiation of DNA 
replication.       
A sustained G1-S arrest is a delayed response that requires transcription, 
translation and protein stabilization of checkpoint transducers and effectors. 
Phosphorylation of the tumor suppressor p53, by ATM/ATR and Chk1/2, stabilizes 
the protein by preventing its interaction with the ubiquitin ligase Mdm2. This leads 
to accumulation of a stable and transcriptionally active p53 in the nucleus. Amongst 
the p53-induced genes is p21, a CDK inhibitor. When p21 reaches a certain threshold 
level it binds and inhibits the S-phase promoting cyclinE-CDK2. By inhibiting the CDK2 
kinase complexes RB is activated, thereby inactivating the transcription factor E2F, 
responsible for transcription of several S-phase genes (12). These events secure the 
maintenance of the G1 arrest.   
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Figure 2: The two pathways of the G1-S checkpoint. The rapid response is due to degradation of 
Cdc25A via ATR/ATM and Chk1/Chk2, leading to inactive CDK2-cyclinE. In the slow response ATR/ATM 
and Chk1/Chk2 stabilizes p53 that in turn transcribes the CDK inhibitor p21. 
Replication initiation 
Chromosome replication takes place in S-phase. It is carefully regulated to 
make sure that the genome is duplicated completely, and that only one copy of the 
genome is made. To ensure this, loading and activation of the replicative helicase are 
separated in time. Preparation for replication begins already in early G1 phase where 
the origin-bound Origin Recognition Complex (ORC) recruits CDC6 to the DNA (13) 
(Figure 3). The minichromosome maintenance proteins (MCM2-7) form a complex 
with Cdt1 before they are recruited by CDC6. The process of loading the MCMs is 
also known as licensing and Cdt1 is an important licensing factor. The newly formed 
complex containing ORC, CDC6, Cdt1 and MCM2-7 is what is known as the pre-
Replicative Complex (pre-RC). The replicative helicase, MCM 2-7, can only be loaded 
in G1-phase (14), and the helicase is activated when S-phase has commenced. To 
ensure this, a series of events must take place before full activation of MCM2-7 is 
achieved. First, while the cells are still in G1-phase the ATP on both CDC6 and ORC 
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are hydrolyzed, leading to the release of both CDC6 itself and Cdt1. Cdt1 is degraded 
and CDC6 is exported to the cytoplasm to guarantee that new pre-RCs cannot form, 
and thereby no re-replications can occur in S-phase (15,16). Secondly, MCM2-7 
becomes phosphorylated and activated in a process that requires both Cell division 
cycle 7-related (Cdc7) protein kinase and S-phase CDK. These processes lead to the 
recruitment of several replication factors needed for full helicase activity, including 
the helicase activating proteins Cdc45 and GINS (17,18). The cells are now in S-phase 
with a fully active replicative helicase, and no means of priming new origins. 
 
Figure 3: Outline of the events in G1-phase leading up to replication initiation. 
Cdt1 
Cdt1 plays a major role in ensuring that re-licensing and thereby re-
replication cannot occur, and is therefore tightly regulated by several mechanisms. 
Binding of Geminin to Cdt1 is the first known mechanism by which Cdt1 is inhibited. 
Geminin is an E2F target and is expressed from S-phase to mitosis. It is thought that 
Geminin binding to Cdt1 blocks the ability to bind MCMs, and Geminin is also 
supposed to stabilize and inhibit Cdt1 through G2 and mitosis making sure that 
formation of pre-RCs can only take place in G1-phase (14). The other means of 
inhibiting Cdt1 are via proteolytic regulation. First, Cdk2 and Cdk4 phosphorylate 
Cdt1 (19). These phosphorylations, in turn, result in the binding of Cdt1 to the SCFSkp2 
ubiquitin ligase complex and the subsequent degradation of Cdt1 (20). Second, Cdt1 
can be proteolytic degraded by the Cul4- DDB1Cdt2 ubiquitin ligase. The association of 
PCNA to Cdt1 both during replication and DNA damage promotes Cul4- DDB1Cdt2 
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directed ubiquitination and degradation of Cdt1 (21).  Recently, a novel role for Cdt1 
outside of replication initiation has also been proposed, namely that Cdt1 
accumulate in G2-phase and has an essential role in the spindle assembly checkpoint 
(22). 
Restriction point 
The Restriction point was described as early as in 1974 as a specific point of 
commitment in G1-phase (23). The cell commits to start a new cell cycle. At the 
molecular level, the Restriction point is defined by the phosphorylation status of the 
retinoblastoma protein (RB) (Figure 4). RB was first discovered as a tumor suppressor 
and is frequently mutated in cancers. RB is known to be phosphorylated by CDK4/6-
CyclinD in early G1-phase. This leaves RB in a hypo-phosphorylated state in which it 
is able to bind and inhibit E2F (24,25). E2F is a family of transcription factors and 
have a range of target genes involved in promoting S-phase, including genes 
encoding replication initiation factors such as Cdt1 (26). In its hypo-phosphorylated 
state RB also binds LAP2α which, via Lamin A/C, anchor RB to the nuclear membrane 
(27). As G1-phase progresses RB is further phosphorylated, now by CDK2-Cyclin E, 
making it hyper-phosphorylated. This hyper-phosphorylation is what most often is 
used as a marker for the Restriction point (28). RB undergoes a conformational 
change that releases RB from its anchor via LAP2α and frees E2F, allowing it to 
translocate into the nucleus and activate transcription of its target genes. The cells 
can now start a new round of the cell cycle. 
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Figure 4: Phosphorylation status of RB through G1-phase. RB activated by CDK4/6-cyclinD allowing 
the binding to both E2F and its nuclear anchor LAP2α. Later in G1-phase RB is hyper-phosphorylated 
by CDK2-cyclinE leading to inactivativation. 
Model organisms 
Model organisms are widely used in research of cell biology. A model system 
is a simpler system that can be easily manipulated. Therefore, when selecting living 
organisms as models to work with, certain criteria are used depending upon the 
experimental purposes. As a result, there is a wide range of characteristics common 
to model organisms, often including short life cycles, small adult size, ready 
availability, and easily manipulated (29). Being small, growing rapidly and being 
readily available are crucial in terms of housing them, given the budget and space 
limitations of research and teaching laboratories. It is of course also important to 
choose an organism where the basic biological processes have been conserved 
through evolution, leaving us with knowledge that can be transferred to human cells. 
To best address a problem of interest make sure that the chosen organism can be 
manipulated in the required way, and that the right techniques are available. 
Schizosaccharomyces pombe 
Schizosaccharomyces pombe (S.pombe) is a unicellular eukaryote belonging 
to the fungus kingdom and shares a common ancestor with the animal kingdom. 
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S.pombe has not specialized to a great extent, making many of the basic mechanisms 
of cell biology equivalent to those found in human cells. Taken together with a short 
generation time and well-developed techniques for genetic manipulation, S.pombe is 
a useful model organism, something that was underlined in 2001 when Paul Nurse 
received the Nobel Prize in Physiology or Medicine for his work on the regulation of 
the cell cycle in S.pombe.  
Human cells 
Human cells in culture are considered a model organism and they contribute 
greatly to the understanding of human biology. There are a variety of techniques 
available for manipulation of human cells in culture, and the relevance to human 
disease is self-evident. Another advantage is the diversity in the different cell lines 
available. A great number of cancer cell lines are available that grow fast and almost 
infinitely. These cell lines can easily be synchronized with drugs like Nocodazole, 
enabling us to study the cell cycle in more detail. Normal fibroblast cell lines are also 
widely used and these cell lines can in addition, be synchronized using contact 
inhibition. This means that when a cell comes in contact with other cells it ceases to 
grow and enter G0-phase. Cells enter G0, a resting phase, when conditions for cell 
growth are not favorable, either by confluency or due to starvation. So why do we 
need other model organisms than human cells to solve biological issues relevant for 
human diseases? Human cells are complex and it can be difficult to deduce why we 
get a certain phenotype after manipulation. Using simpler unicellular eukaryote 
organisms such as yeast makes it easier to understand how the basic mechanisms 
work. The principles discovered in simpler organisms can then be transferred to 
human cells and help decipher complex pathways. Combining human cell culture and 
other model organisms will help us get a better understanding for the fundamentals 
leading to human diseases.  
Novel G1-S checkpoint 
The G1-S checkpoint described above has not been observed in S.pombe, and 
together with the very short G1-phase in culture, G1-phase has not been widely 
studied due to technical reasons. However, synchronizing the cells using a 
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temperature-sensitive cdc10 mutant will ease investigation of G1-phase issues. 
Cdc10 is a transcription factor much like E2F, responsible for the transcription of 
several genes, including cdt1 and cdc18 (CDC6), necessary for the transition from G1-
phase to S-phase. The temperature-sensitive mutant has a mutation that hinders the 
correct protein folding when the cells are grown at 36oC. Leaving the cells at 36oC for 
4 hours ensures that all cells have completed a cell cycle and are in early G1-phase, 
unable to move further until cdc10 transcripts are available again. Irradiating cells 
with UV just after release from such a cdc10 block resulted in a G1-block (30). This 
delay was independent of Rad3 (ATR), Chk1 and Cds1 (Chk2), and did therefore not 
display the molecular hallmarks of the known checkpoint response. It was also 
shown that the UV-irradiation induced a delay in the formation of pre-RC, causing 
the delay in S-phase entry, and that this was totally dependent on the kinase Gcn2 
(31). Unexpectedly, this response to UV early in G1-phase is not the same for all 
types of DNA damaging agents. Methyl methane sulphonate (MMS) and hydrogen 
peroxide (H2O2) does induce a G1-arrest. Ionizing radiation (IR) and psoralen in 
combination with UVA (PUVA) on the other hand, does not cause a cell cycle 
delay.(32), indicating that this is not a general DNA-damage checkpoint. More recent 
studies have concluded that the G1-S delay is dependent on some form of DNA 
damage. However, the activating signal does not derive from the initial DNA damage 
but from one or more repair intermediates (33). 
GCN2 
GCN2 (General control non-derepressible 2) is a serine/threonine-protein 
kinase that was first discovered to be part of a pathway that responds to amino acid 
deprivation and survival in Saccharomyces cerevisiae (S.cerevisiae) (34). Uncharged 
tRNAs accumulate in the cell due to amino acid starvation and they bind to a histidyl-
tRNA synthetase domain of GCN2, leading to autophosphorylation at specific 
residues in the protein kinase domain and dimerization (35,36). The active GCN2 
dimer can efficiently phosphorylate Serine51 (Ser51) on the α subunit of eukaryotic 
translation initiation factor 2 (eIF2α) (37). As the name indicates, eIF2 is important 
for the initiation of translation. When eIF2 is in a GTP-bound form it delivers the 
initiator methionyl tRNA (met-tRNAi) to the ribosome. Once protein synthesis is 
13 
 
initiated the GTP is hydrolysed and eIF2 is released from the ribosome in a GDP-
bound form. eIF2 needs to be recycled to a GTP-bound form by eIF2B, a guanine 
nucleotide exchange factor (GEF). However, the phosphorylation by GCN2 on eIF2α 
transforms eIF2 to a competitive inhibitor of eIF2B, thought to lead to global 
downregulation in protein synthesis, and thereby reducing the utilization of amino 
acids (Figure 5). Even though global translation is reduced, eIF2α phosphorylation 
does also induce increased translation of specific mRNAs containing upstream open 
reading frames (uORFs), such as GCN4 in S.cerevisiae or ATF4 in mammals (37). ATF4 
and GCN4 are transcriptional regulators that control hundreds of genes, many of 
which are involved in amino acid regulation.  
Several studies from work with S.cerevisiae have led to a model of how GCN2 
detects uncharged tRNA after starvation (38-41). A scaffold protein, Gcn1, is found 
to promote Gcn2 activity when the equivalent charged tRNA is scarce, either by 
positioning Gcn2 close to the ribosome or more directly, delivering uncharged tRNA 
from the ribosome, to Gcn2. GCN1 is conserved in mammals and is shown to co-
immunoprecipitate with GCN2 (38). An inhibitor of the interaction between GCN2 
and GCN1, IMPACT, has been shown to impair GCN2 activation not only after amino 
acid starvation, but also after UV-irradiation, glucose starvation and proteasome 
inhibition when overexpressed (42). 
GCN2 is not the only kinase to phosphorylate Ser51 on eIF2α. In mammalian 
cells there are a total of four kinases that give the same downstream effect of eIF2α 
phosphorylation; GCN2, PKR, HRI and PERK, each of which respond to different 
stimuli (Figure 5). In S.pombe three kinases, Gcn2, Hri1 and Hri2, phosphorylate 
eIF2α.  
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Figure 5: Translational regulation by eIF2. In its GTP-bound form eIF2 delivers met-tRNAi to the 40S 
ribosomal subunit to initiate translation. eIF2 need to be recycled back into a GTP-bound form by 
eIF2B, however if eIF2 is phosphorylated by GCN2, PKR, HRI or PERK the eIF2-eIF2B interaction is 
stabilized inhibiting global translation, but not translation of specific target genes such as GCN4 in 
yeast and ATF4 in mammalian cells. 
 
GCN2 has been linked to diseases such as cancer and Alzheimer’s, and is 
reported to be involved in a large array of biological functions that are not directly 
coupled to amino acid starvation, such as the novel G1-S checkpoint in S.pombe 
(38,43,44). The function of GCN2 is therefore likely to exceed the current knowledge. 
Like in S.pombe, UV-irradiation has been shown to activate GCN2 and downregulate 
translation in mammals (45). However, there is no indication of UV-irradiation 
resulting in accumulation of uncharged tRNAs, and it has been suggested that GCN2 
activation is due to either UV crosslinking tRNAs to GCN2, causing activation (45) or, 
in the case of  UVB, causes a swift consumption of arginine when nitric oxide is 
produced from it with the aid of nitric oxide synthetase (46).  
In a more recent study GCN2 was reported to phosphorylate methionyl-tRNA 
synthetase (MRS) after UV-irradiation (47). MRS is part of a multisynthetase complex 
and catalyzes the attachment of methionine to both the initiator tRNA as well as the 
tRNAmet required for elongation (48). Under normal conditions MRS strongly 
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associates with the tumor suppressor AIMP3. However, after UV-irradiation the 
phosphorylated MRS is reported to undergo a conformational change that blocks 
tRNA binding and causes the dissociation of AIMP3 (47). AIMP3 then supposedly 
translocates to the nucleus and mediates DNA damage repair in an unknown 
manner.  
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Aim of study 
Checkpoints are of great importance for the cells to maintain genomic stability and 
represent the first barrier against cancer. Our group described a novel checkpoint 
governing the G1-S transition after UV irradiation in S.pombe. The mechanism was 
different from the classic G1-S checkpoint, both considering its mechanism of action 
and its target. The checkpoint is absolutely dependent on the Gcn2 kinase and it 
delays entry into S-phase by delaying the formation of the pre-replicative complex, a 
obligatory step in the preparation for DNA replication. 
The overall aim of this study was to investigate the role of GCN2 in G1-phase and the 
regulation of pre-RC formation in mammalian cells: 
Paper 1) The aim of this work was to develop a method that allows us to 
investigate pre-RC loading in mammalian cells. This method was combined with 
detection of RB, allowing us to study the timing of both pre-RC loading and the 
restriction point in single cells, both important events in G1. 
Paper 2) The aim of this work was to study the effects of GCN2 in cell-cycle 
regulation, both after stress and in unstressed cells 
Paper 3) The aim of this work was to investigate the mechanism of GCN2 
activation after different stresses.  
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Summary of results 
Paper I 
Loading of the pre-Replicative Complex (pre-RC) and the Restriction point are well 
studied events in G1-phase. These events are important for the cell to maintain 
genomic integrity. Hyper-phosphorylation of the tumor suppressor Retinoblastoma 
protein (RB) is commonly used as a marker for the Restriction point. Hyper-
phosphorylation of RB leads to the release of the transcription factor E2F. The 
relative timing of pre-RC formation and the Restriction point and their 
interdependence is not clear. Several pre-RC components are listed as E2F targets 
and it is therefore often suggested that pre-RC formation must come after the 
Restriction point. We have developed a novel method that allows us to measure the 
timing of these events in single cells. We take advantage of the fact that 
minichromosome maintenance (MCM) proteins bind chromatin during pre-RC 
formation and that RB is anchored to the nucleus before it is hyper-phosphorylated. 
Extracting all unbound proteins thereby allows us to study the loading of pre-RCs 
and hyper-phosphorylation of RB as well as the order of these events. We find that 
the timing of pre-RC loading and the Restriction point varies between cell types and 
between synchronization methods. In U2OS cells both the Restriction point and pre-
RC loading occur earlier in G1-phase than in BJ cells. In both cell lines, when growing 
exponentially, contain a small fraction of cells that load MCMs before the Restriction 
point. Furthermore, U2OS cells released from a Nocodazole block are able to load 
pre-RC prior to the Restriction point. We therefore conclude that there is no strict 
inter-dependence between pre-RC loading and the Restriction point, and E2F-driven 
transcription is not essential for pre-RC formation. 
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Paper II 
Our group has previously described a checkpoint governing the G1-S transition in 
S.pombe. Cells exposed to UV-irradiation delay pre-RC formation and therefore entry 
into S-phase in a GCN2-dependent manner. GCN2 is a protein kinase known to be 
involved in translational regulation. Its best characterized substrate is eIF2α, an 
important factor for initiation of translation. The GCN2 checkpoint regulates the 
loading of the pre-RC, independently of known checkpoint regulators such as Rad3 
(ATR), Chk1 and Cds1 (Chk2). Here we find that GCN2 can regulate pre-RC loading 
also in mammalian cells. Cells depleted of GCN2 show significantly less delay in the 
loading of pre-RCs after UV-irradiation. We also find that GCN2 can regulate the level 
of Cdt1, a component of pre-RC, in unstressed cells.  Depletion of the transcription 
factor ATF4, a well-characterized target of GCN2-eIF2α, did not have any effect on 
the level of Cdt1, indicating that the regulation of Cdt1 is not via eIF2α-ATF4, the 
best known pathway of GCN2. We also observed that neither Cullin4 nor 
proteasome inhibition appeared to bring the level of Cdt1 up to the control level, 
indicating that GCN2 does not regulate Cdt1 via protein degradation. These data 
suggest that GCN2 has a novel role(s) in mammalian cells, and can regulate pre-RC 
both in stressed and unstressed cells. 
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Paper III 
The molecular mechanism of GCN2 activation has been extensively studied in 
S.cerevisiae, where the scaffold protein GCN1 is required for GCN2 activation. GCN1 
facilitates the delivery of uncharged tRNAs from the ribosome to GCN2. However, 
accumulation of uncharged tRNAs is not a known consequence of either UV- or H2O2-
exposure. Both stresses are shown to activate GCN2, leading us to speculate that 
GCN2 can be activated by other mechanisms than via uncharged tRNAs and GCN1. 
By deleting gcn2 in S.pombe we find that Gcn1 is required for GCN2 activation after 
amino acid starvation, but not after exposure to UV-irradiation or H2O2. We also find 
that ongoing translation is not required for UV-induced activation of Gcn2 in 
S.pombe, suggesting that uncharged tRNAs are not necessary for Gcn2 activation 
after UV-irradiation. Surprisingly, in mammalian cells GCN1 seems to be required for 
GCN2 activation after UV-irradiation but not after amino acid or serum starvation, 
indicating that the importance of GCN1 for GCN2 activation may differ from 
organism to organism. We also find that a mechanism previously described after 
UVB-irradiation and involving arginine starvation resulting from NOS activation does 
not contribute to initial activation of GCN2 after UV (UVC)-irradiation in mammalian 
cells. These results suggest that GCN2 is not activated by uncharged tRNA after UV in 
mammalian cells either. To test whether GCN2 was activated by any of the kinases 
mTor, ATR, ATM, DNA-PK and Chk1, we treated U2OS cells with appropriate 
inhibitors and found that none of these inhibitors reduced the UV-induced eIF2α 
phosphorylation. Our findings suggest that GCN2 can be activated by other 
mechanism than that involving GCN1 and uncharged tRNAs in both S.pombe and 
mammalian cells. 
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General discussion and further work 
We have developed a novel method to investigate the phosphorylation status of RB 
and chromatin-bound MCMs (Paper I). This method allowed us to study the loading 
of MCMs after exposure to UV-irradiation. We have found that GCN2 does take part 
in the regulation of pre-RC formation after UV-irradiation and, in addition, regulates 
Cdt1 in an unperturbed cell cycle (Paper II). We have also investigated the activation 
of GCN2 in response to different stresses in both S.pombe and mammalian cells, and 
find that GCN2 can be activated by other means than via GCN1 and uncharged 
tRNAs. The work in this thesis has broadened our understanding of mechanisms 
regulating the G1-S transition in mammalian cells. I will now discuss the findings and 
experimental considerations as well as speculate on future work.  
A novel G1-S checkpoint in mammalian cells 
There are several mechanisms preventing entry into S-phase when DNA is 
damaged by UV-irradiation. ATR/ATM can be activated in the classic checkpoint and 
induce a G1 arrest as described in the Introduction. But there are also two pathways 
that can be activated earlier in G1. Both these pathways delay pre-RC formation 
(figure 1). First the cells can degrade Cdt1 in a Cul4-DDB1Cdt2 dependent manner. 
This pathway is conserved from S.pombe (49) to mammalian cells (21,50,51). 
Second, the novel Gcn2-dependent checkpoint also delays the pre-RC formation. The 
checkpoint we have discovered in S.pombe did not appear to be dependent on Cdt1. 
However, fission yeast also has the Cdt2-dependent Cdt1 degradation pathway and 
we reason that the role of Gcn2 was possible to reveal by our experimental system. 
As explained earlier these experiments were done by synchronizing the cells using a 
Cdc10 block. By using this method the level of Cdt1 is reduced to a minimum. The 
delay we see in the loading of MCMs and the eIF2α phosphorylation is therefore 
Cdt1 independent and Gcn2 dependent. Synchronizing the cells using a mitotic block 
reveals the Cdt2-dependent Cdt1 degradation, but at the same time it masks the 
Gcn2-dependent checkpoint. This indicates that the GCN2 dependent delay is 
overpowered by the delay caused by the degradation of Cdt1. In mammalian cells 
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Cdt1 was present at the start of all our experiments, implying that any delay in the 
loading we see after UV-irradiation is at least in part due to degradation of Cdt1. 
However, we do see a partial effect of GCN2, suggesting that there are two possible 
pathways that can delay pre-RC loading in G1-phase after UV, one dependent on 
Cdt1 degradation by Cdt2 and its upstream regulators like ATR and the other 
dependent on GCN2. 
  
Figure 1: Pathways delaying pre-RC formation after UV-irradiation. Blue arrows indicate 
Cdt1 degradation. Brown arrows indicate the GCN2-dependent checkpoint. 
 
GCN2 regulates ATF4 in unstressed cells 
Activation of GCN2 inhibits the ternary complex consisting of eIF2, GTP and 
methioninyl-initiator tRNA (Met-tRNAmet), by phosphorylating eIF2α. This inhibits 
further rounds of translation initiation (52). However, a number of mRNAs 
containing uORFs (upstream open reading frames) upstream of the protein-coding 
ORFs are selectively transcribed (34,53). One of the GCN2-eIF2αP targets is the 
transcription factor ATF4. The GCN2-eIF2αP-ATF4 pathway is shown to be critical for 
maintaining metabolic homeostasis in tumor cells (54). ATF4 is known to upregulate 
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genes involved in amino acid import, glutathione biosynthesis, and resistance to 
oxidative stress. Because we find that the downregulation of Cdt1 after GCN2 
deletion is not due to protein degradation, one possibility could be a downregulation 
in transcription. However, we also find that downregulation of Cdt1 is ATF4 
independent. Nevertheless, it is possible that ATF4 also has a role in unstressed cells 
and that this could be regulated by GCN2. That would mean that depleting GCN2 
would reduce the ATF4 level and thus reduce transcription of its target genes. We 
have done preliminary experiments where we deplete ATF4 and GCN2 with siRNA 
and run whole cell lysates on immunoblot interestingly, we do see that GCN2 
regulates ATF4 in unstressed cells, indicating a role for GCN2 beyond stress 
regulation (figure 2).  
GCN2 regulates Cdt1 
In Paper II we clearly see that GCN2 can regulate Cdt1, but the transfection 
efficiency has been varying during the experimental work. We experienced that 
when depleting GCN2 by siRNA transfection, we only saw a reduction in Cdt1 when 
the GCN2 level were reduced by 75% or more. We experienced a change in the cell 
growth conditions when we moved to another laboratory and found it difficult to 
continue with the seeding density required for the transfection reagent we were 
using. We therefore changed transfection reagent, allowing more flexibility in the 
seeding density of the cells. The fact that GCN2 needed to be reduced substantially, 
indicate that GCN2 is in excess in the cells and that activation of only a proportion of 
the kinase is enough for a response. Indeed, we did observe some induction of eIF2α 
phosphorylation after UV-irradiation even when GCN2 was knocked down (data not 
shown). It is also likely GCN2 regulates Cdt1 indirectly through other selectively 
translated genes. It would be interesting to immunoprecipitate GCN2 or Cdt1 to 
investigate if there could be a direct interaction between the two proteins. 
Performing mass spectrometric analysis of Cdt1 from cell with or without GCN2 
could also provide us information about any GCN2-dependent modifications. 
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Figure 2: Cdt1 does not appear to be regulated by ATF4. U2OS cells were transfected with 
siGCN2 or siATF4. Whole cell lysates were analyzed by immunoblots for ATF4 and GCN2. 
Loading control: Lamin 
The effect of Cdt1 reduction 
We have shown that the protein level of Cdt1 is reduced when depleting 
GCN2 (Paper II). We were expecting that a reduction in the level of Cdt1 would 
induce some form of cell-cycle defect, because Cdt1 is required for the loading of the 
MCM helicase. A reduction in the Cdt1 level could lead to a prolonged G1-phase due 
to problems loading the right amount of pre-RCs. The cells could also possibly enter 
S-phase with too few pre-RCs formed. Fewer licensed origins would lead to a greater 
distance between origins, meaning that the replication forks would have to travel 
further without stalling (55). But the greater the distance between forks the more 
likely it is to encounter fork stalling and subsequently fork collapse. If a reduction in 
the Cdt1 level does induce fork collapse we would have expected there to be DNA 
damage in S-phase. We have labelled cells depleted for GCN2 with EdU, a thymidine 
analog, allowing us to identify cells in S-phase after analysis by flow cytometry. 
However, we did not observe any significant difference in the S-phase population 
when compared to control cells (date not shown), and cannot conclude that GCN2 
depleted cells spend longer time in S-phase. We have also stained cells with 
antibodies recognizing γH2AX or 53BP1, both marker for DNA damage, and found no 
clear indications of increased DNA damage after GCN2 depletion (data not shown). 
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However, it does appear that GCN2-depleted cells have more micronuclei than 
control cells. Micronuclei are small nuclei that are formed when chromosomes or 
fragments of chromosomes are not properly segregated into one of the daughters 
during cell division. Depletion of GCN2 could therefore cause defects in mitosis and a 
recent paper has suggested a novel role for Cdt1 in mitosis (22). In this paper they 
observed that Cdt1 binds to the Ndc80 complex that links the microtubules to the 
kinetochore and helps ensure proper segregation of chromosomes during mitosis 
(56). In the absence of Cdt1 the Ndc80 complex was found to be highly bent, but in 
the presence of Cdt1 the structure was elongated. Our own observations of 
microtubule assembly and disassembly might also be related to this chromosome 
segregation phenotype. In S.pombe, leaving the cells on ice for 30 minutes 
disassemble the microtubules, but rapid reassembly can be seen when the cells are 
returned to 25oC. A Gcn2-/- strain however, appears to struggle to rebuild 
microtubules after exposed to cold shock (data not shown). These findings are very 
interesting and it would be exciting to follow microtubule dynamics after a cold 
shock in mammalian cells with and without GCN2, using live-cell imaging. In addition 
it would be interesting to deplete cells for Cdt1 and see whether there are 
phenotypes mimicking those we observe in GCN2 depleted cells. This might reveal a 
role of GCN2 in mitosis. 
A link between GCN2 and ATR  
GCN2 is a large protein of around 190 kDa. When the cells have been 
exposed to UV immunoblots contain an additional, GCN2-specific band above the 
usual band for GCN2 (figure 2). The appearance of the upper band correlates with 
activation of GCN2. The upper band also corresponds to the band we observe when 
using an antibody against the GCN2 autophosphorylation site at threonine 898 
(figure 2). Surprisingly, we also observe such a band-shift when the cells are treated 
with VE-821, an ATR inhibitor. The band-shift we observe after the ATR inhibitor is 
not as prominent as after UV-irradiation, but it appear together with increased eIF2α 
phosphorylation, again suggesting GCN2 activation. ATR is essential in mammalian 
cells and to investigate whether this activation of GCN2 is due to general stress when 
ATR is inhibited we treated the cells with the inhibitor for different lengths of time. 
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We observed that even with an incubation time of 15min GCN2 was activated (figure 
2). Preliminary data also show that entry into S-phase is delayed when the ATR 
inhibitor was added in early G1-phase (Bøe et.al manuscript in preparation). These 
data indicate that ATR may have a role in G1-phase that involves GCN2.  In 
S.cerevisiae the ATR homolog Mec1 regulate Ribonucleotide reductase (RNR) by 
inhibiting Sml1, an RNR inhibitor (57). It has also been shown that GCN2 is activated 
by nucleotide starvation in budding yeast (58) as well as in fission yeast (our 
unpublished results),  leading us to speculate that  ATR inhibition results in a 
reduction of nucleotide levels also in mammalian cells, thereby activating GCN2. 
Interestingly, we have preliminary result showing that in S.pombe Cid13, a 
poly(A)polymerase accountable for increasing the RNR level, is found in the 
polysome fraction after UV. This indicates that Cid13 is translated and therefore is a 
potential target of GCN2. An interesting speculative model supported by these 
observations is that GCN2 is activated either directly by ATR or by the level of 
nucleotides. The level of nucleotides is tightly regulated through the cell cycle (59), 
making it more plausible that a reduction in nucleotide levels after ATR inhibition 
would activate GCN2 after only 15min. The activation of Gcn2 could lead to 
increased Cid13 translation and thereby suc22 (an RNR subunit) mRNA stabilization 
and increased translation to increase nucleotide levels. 
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Figure 2: ATR inhibitor activates GCN2. U2OS cells were treated with ATR inhibitor (ATRi) for 
the times indicated (right). UV-irradiation was given at 60J/m2 and recovery for 1h. Whole-
cell lysates were analyzed by immunoblotting for GCN2, Phospho-GCN2 (Thr898) and eIF2α-
P. Chk1 P317 was used as an indicator on the effect of the ATRi. Loading control: γ-tubulin 
(γ-tub)   
In a recent paper, a novel role of GCN2 has been described. It was shown that 
GCN2 phosphorylates methionyl-tRNA synthetase (MRS) in response to UV (47). MRS 
is an aminoacyl-tRNA synthetase (ARS), a group of essential proteins linking amino 
acids with their correct tRNA (60). MRS is necessary to make sure Met-tRNAmet is 
available to form the ternary complex together with eIF2α and GTP. Phosphorylation 
of MRS by GCN2 leads to a reduction in Met-tRNAmet and thereby a downregulation 
of global protein synthesis (47). An additional effect of phosphorylating MRS is that it 
induces a conformational change that releases the tumor suppressor AIMP3 (p18) 
from the complex (47). AIMP3 then translocates into the nucleus where it can 
activate a DNA damage response via ATR/ATM (61-63). It was also demonstrated 
that MRS is phosphorylated prior to eIF2α (47). This may indicate that MRS induces 
the initial downregulation of global translation whereas eIF2α-P is responsible for 
selective translation to counter effect the damage/translational downregulation.  
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The role of GCN1 
We find that GCN1 is not required for activation of eIF2α after serum 
starvation or amino acid starvation in mammalian cells (Paper III). This is in contrast 
to findings in S.cerevisiae. Furthermore, the requirement for Gcn1 for Gcn2 
activation after amino acid starvation is conserved between S.cerevisiae and 
S.pombe. UV-irradiation does not require Gcn1 for Gcn2 activation in S.pombe but it 
seems to be required in mammalian cells.  
The proposed role of GCN1 for GCN2 activation in budding yeast is to ensure 
transfer of the uncharged tRNAs arriving at the ribosome A site (41). Accumulation 
of uncharged tRNAs is not a known consequence of either UV- or H2O2-exposure, 
and in combination with Gcn1 not being required after UV or oxidative stress in 
S.pombe, these findings suggest the existence of a novel pathway of activating GCN2. 
Serum starvation also activated eIF2α in the absence of GCN1, which could suggest 
that serum starvation activated GCN2 in a similar way as UV or that it is rather one of 
the other eIF2α kinases that are responsible for this activation. It has been shown 
that glucose starvation activates GCN2 in S.cerevisiae (64), however in mammalian 
cells it have been shown that PERK is  the primary kinase responsible for eIF2α-P 
after glucose starvation (65), an eIF2α kinase not present in either S.cerevisiae or 
S.pombe. The interplay between GCN1 and GCN2 has been widely studied in 
S.cerevisiae (38). However, only one paper has reported experimental evidence that 
GCN2 requires binding to GCN1 for activation in mammalian cells (42), and in this 
paper they overexpressed a fragment of GCN1 which resulted in impaired function of 
GCN2. It is on the other hand not unlikely that GCN1 would interact with other yet 
unknown proteins, since it contains >20 HEAT repeats that are proposed to function 
as interaction sites (66), and one could imagine that overexpressing parts of a 
protein could induce unphysiological effects. It is also important to note that in our 
amino acid starvation experiments in mammalian cells, we starved the cells for 
glutamine, cysteine and methionine. Most studies in S.cerevisiae have been 
performed with either leucine or histidine starvation. Mammalian cells depleted for 
ATF4 are particularly sensitive to asparagine starvation and ATF4 regulates 
29 
 
asparagine synthetase (54). It is therefore possible that the effect is not the same for 
all amino acids.  
I order to unambiguously determine the involvement of tRNA binding it 
would be interesting to mutate the tRNA-binding domain in GCN2 and transfect this 
version of GCN2 into GCN2-/- cells. This would allow us to study the effect of this 
domain after several stresses and could give us an indication of whether binding of 
uncharged tRNAs is required for GCN2 activation under these conditions. 
GCN2 and disease 
GCN2 has been implicated in several diseases including cancer and 
Alzheimer’s (38). Cancer cells depend on GCN2 for survival and proliferation and this 
is thought to be because of its role in starvation responses (54).  In acute 
lymphoblastic leukemia the cells are unable to synthesize the amino acid asparagine. 
Treating these cells with asparaginase hinders the cells in acquiring asparagine from 
the circulations around the cell, leading to cell death. Interestingly, studies suggest 
that inhibiting GCN2 may enhance the effect of this drug even further (67). In 
Alzheimer’s disease, suppressing GCN2 in mouse models lead to a decreased eIF2α 
phosphorylation, and an alleviation of memory impairments and synaptic failure, but 
how GCN2 is linked to synaptic failure and memory defects is still unknown (68). 
GCN2 is to an increasing extent being implicated in biological processes seemingly 
unrelated to responses to amino acid starvation (reviewed in 38).  Our findings of a 
novel role for GCN2 could give new insight to the biological functions of GCN2. This 
knowledge can then be exploited in targeting GCN2 for therapy and possibly for 
combination therapy approaches. 
The Restriction point 
I find the timing of the Restriction point an interesting topic. It was first 
reported that the Restriction point occurs 2-3h prior to S-phase entry (69). However, 
we find, in agreement with Stokke et.al (70), that the Restriction point, as measured 
by RB hyper-phosphorylation, occurs around 6h prior to S-phase entry. Cancer cells 
are often deficient in the G1-S checkpoint and we observed that  U2OS cells released 
from a mitotic shake-off, are past the Restriction point already after 15 minutes and 
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that they enter S-phase 6-7 hours after release (data not shown). Passing the 
restriction point immediately after the cells enter G1-phase leave them no time to 
evaluate whether the conditions are right for committing to a new round of the cell 
cycle. When doing a mitotic shake-off only the cells in mitosis at this moment (1-2% 
for U2OS cells) are detached by physically shaking the flask. This should disturb the 
cell cycle minimally, in contrast to a mitotic block-and-release experiment, where the 
cells are arrested in metaphase by Nocodazole. Upon release from Nocodazole, both 
the Restriction point and entry into S-phase is delayed by about 3 hours as compared 
to a mitotic shake-off, but the duration of G1 after the restriction point remains the 
same. Also normal fibroblast cells (BJ) seem to pass through the Restriction point 
around 6 h prior to S-phase entry, meaning that the variations we see between 
different cell lines in cell-cycle length, may very well be due to the variations in time 
spent in G1-phase prior to the Restriction point. It is interesting that the cells need to 
spend so long after passing the Restriction point before entering S-phase. There are 
undeniably several S-phase genes that need to be transcribed. These genes also 
need to be translated before they can start doing their responsibilities, but if this 
takes around 6h is unknown. 
Ionizing and UV irradiation affect RB and MCM 
differently 
In paper I we showed that ionizing radiation (IR) blocked the loading of 
MCMs and the phosphorylation of RB. Cyclin D-Cdk4/6 becomes constitutively active 
after DNA damage induced by doxorubicin, a topoisomerase II inhibitor causing 
double strand breaks (24). After this treatment RB becomes hypo-phosphorylated, 
consistent with our findings after IR. However, because we observed that some cells 
are able to load MCMs prior to RB hyper-phosphorylation we do not believe that the 
block of RB hyper-phosphorylation after IR is the cause of delayed loading of MCMs. 
Cdt1 is, however, rapidly degraded after IR (50,71), and the degradation of Cdt1 will 
block the loading of MCMs and explain the effect we see after IR. 
It should be noted that in S.pombe we have previously shown that IR does 
not affect pre-RC loading (32). However, these experiments were done by 
synchronizing the cells with a cdc10 block-and-release (as explained in the 
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introduction). An additional target of Cdc10 is Cdt2, a substrate receptor protein for 
the E3 ubiquitin-ligase complex responsible for the degradation of Cdt1 (49). This 
implies that after a Cdc10 block-and-release Cdt2 is not present to be activated by IR 
and can therefore not degrade the Cdt1 that is produced. IR may therefore not affect 
the pre-RC loading after a Cdc10 block-and-release. 
In addition to the IR (Paper I), we also investigated the relative timing of the 
restriction point and MCM loading after UV. The flow cytometric analysis of the RB 
phosphorylation it appeared very different from what we observed after IR (figure 
3A). In the IR experiments the cells were all RB-positive (Q3), whereas in the UV 
experiment the cells all appear RB-negative (Q4). This could indicate that the cells 
stop at a later stage in the cell cycle (after RB hyper-phosphorylation). However, if 
the protein level of RB is significantly reduced by the UV-irradiation this would also 
change the RB-staining pattern as if they stop at a later stage in G1-phase. 
Immunoblot analysis showed that RB was not hyper-phosphorylated after UV 
irradiation (RB upper band figure 3B) as we showed for the cells treated with IR 
(Paper I figure 2A). This leads us to conclude that there is less RB after exposure to 
UV (figure 3B). An attractive hypothesis is that MDM2 might be responsible for the 
reduction in RB levels after UVC irradiation. MDM2 is an E3 ligase and it has been 
shown to promote RB degradation (72). It has also been shown that MDM2 binds 
selectively to hypo-phosphorylated RB inhibiting the RB-E2F interaction (73), leading 
us to speculate that MDM2-binding to RB might prevent RB anchoring to the 
nucleus. Intriguingly, MDM2 is also shown to have transcript variants containing 
uORF, a known trait of GCN2-eIF2α-P target genes. It would therefore be interesting 
to see if GCN2 affects the level of MDM2 and the reduction in RB protein level after 
UVC-irradiation and to investigate if the uORF of MDM2 has similarities with the 
uORF of ATF4. 
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Figure 3: RB appears different in synchronized BJ cells in response to UV and IR. A) BJ cells 
synchronized by contact inhibition was treated with UV (60J/m2) or IR (6Gy) 1h after release 
and were extracted and fixed 24h after release. The samples were analyzed by flow 
cytometry. B) BJ cells synchronized by contact inhibition was treated with UV (60J/m2) 1h 
after release and fixed at time points indicated. Whole cell lysates were analyzed by 
immunoblotting for RB. γ-tub was used as a loading control. 
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Gating the right population after flow cytometry 
Studying the timing of RB hyper-phosphorylation and the loading of MCM is 
based on whether or not the cells contain MCMs or RB after extraction. This implies 
that it is important that the gates are set correctly. Gating of the RB-positive cells 
was quite straightforward. There was a clear drop in RB staining once the cells 
entered S-phase and there were also two distinct populations in the G1-population, 
making it easy to separate positive from negative cells. The clear drop in RB staining 
also indicates that rather than a gradual phosphorylation event, all RB in a single cell 
becomes hyper-phosphorylated at one time. For the MCMs a clear positive and 
negative population was not obvious in all experiments, suggesting that there is a 
continuous loading of MCM proteins throughout G1-phase. Several papers have 
shown that there are two populations of MCM-positive cells in G1 (74,75) and it has 
also been shown that MCMs load gradually during the course of G1 phase with 
maximum loading preceding S phase (76). We therefore decided to use the decline 
we observe in loaded amounts of MCM when setting the gate for MCM positive 
cells.  We argue that when replication is completed in S-phase the MCM are 
subsequently off-loaded and the cells in G2/ M are expected to be MCM-negative. It 
is also important to note that in Paper II we use the median value of MCMs in G1-
phase, rather than just the positive cells. This allows us to determine if there is a shift 
in the overall level of MCMs in extracted cells. 
Loading of MCMs in mitosis 
It is worth noting that an MCM-positive G2/M population can be observed in 
exponentially growing BJ cells (paper I, figure 4A). It is therefore likely that some BJ 
cells start loading MCMs before cytokinesis is completed, in agreement with 
previous reports of MCM loading occurring in late mitosis (77,78).  In contrast, 
exponentially growing U20S cells did not show MCM loading in cells with G2/M DNA 
content (Paper I figure 1A and figure 4A). However, when mitosis was prolonged 
after Nocodazole treatment of U2OS cells, we consistently observed a fraction of 
MCM-positive G2/M cells (Paper I figure 5). We cannot separate G2 and M cells 
based on DNA content. But, histone H3 (phosphor S10) (H3P) antibody is often used 
as a mitotic marker. This phosphorylation is crucial for chromosome condensation 
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and progression through mitosis. The phosphorylation remains high until metaphase 
and in anaphase H3 is gradually dephosphorylated (79), leaving the cells H3P 
negative at the end of mitosis. We have seen that the H3P-positive population is not 
included in the MCM-positive population we observe in G2/M (data not shown), 
suggesting that MCM only start loading once the cells pass anaphase. 
Concluding remarks 
We have mainly been focusing our work on GCN2 in G1-phase, and it clearly 
has a role there, but that does not exclude that GCN2 has functions in other cell-
cycle phases. We have indication that GCN2 does have other roles than what is 
currently known. For example, we observed that GCN2-depleted cells grow more 
slowly than wild-type cells. We also observe that Nocodazole affects GCN2-depleted 
cells more severely than wild-type cells and that GCN2-depleted cells appear to have 
more micronuclei suggesting a role in mitosis. These phenotypes are difficult to 
explain solely based on current knowledge. We are confident that GCN2 will be an 
interesting subject for future studies, and most likely more substrates will be 
identified.  
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